NovoLog and Novo Nordisk’s other rapid-acting insulin follow-on Fiasp are among the drugs subject ... endorsed Eli Lilly’s version of the drug, called Rezvoglar (insulin glargine-aglr).
Novo Nordisk has developed a new version of the insulin analogue, called Fiasp, which added another ... Office of New Drugs in the FDA's Centre for Drug Evaluation and Research (CDER), said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results